The low utility of pretherapy scans in thyroid cancer patients
F Pacini, MJ Schlumberger - Thyroid, 2009 - go.gale.com
RADIOIODINE (RAI) is administered postoperatively in three contexts: the ablation of normal
thyroid remnants will facilitate the subsequent follow-up with serum thyroglobulin …
thyroid remnants will facilitate the subsequent follow-up with serum thyroglobulin …
Estimation of the release time from isolation for patients with differentiated thyroid cancer treated with high-dose I-131
JH Lee, SG Park - Nuclear medicine and molecular imaging, 2010 - Springer
Purpose Patients receiving high-dose I-131 to treat differentiated thyroid cancer are isolated
from visitors to limit radiation exposure to reasonable levels. The appropriate isolation time …
from visitors to limit radiation exposure to reasonable levels. The appropriate isolation time …
Outpatient thyroid remnant ablation using repeated low 131-iodine activities (740 MBq/20 mCi× 2) in patients with low-risk differentiated thyroid cancer
J Clerc, M Bienvenu-Perrard… - The Journal of …, 2012 - academic.oup.com
Context: In low-risk differentiated thyroid cancer (DTC), postoperative 131I remnant ablation
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
[HTML][HTML] Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort
Abstract I-131 radioiodine (RAI) ablation removes postoperative residual tissue and
facilitates follow-up in low-and intermediate-risk differentiated thyroid cancer (DTC) …
facilitates follow-up in low-and intermediate-risk differentiated thyroid cancer (DTC) …
One Size Does Not Fit All: The Merit of Absorbed Doses to the Blood in: 131: I Therapy for Differentiated Thyroid Carcinoma
L Fatholahi, F Tabeie, AM Pashazadeh, H Javadi… - Health …, 2015 - journals.lww.com
The amount of 131 I necessary for successful ablation in patients with differentiated thyroid
cancer (DTC) is still subject to debate. This study investigates the relationship of the …
cancer (DTC) is still subject to debate. This study investigates the relationship of the …
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole‐body …
M Salvatori, G Perotti, V Rufini… - Clinical …, 2004 - Wiley Online Library
Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
[PDF][PDF] Prospective randomized trial for evaluation of efficacy of low versus high dose I-131 for post operative remnant ablation in differentiated thyroid cancer
S Sirisalipoch, V Buachum, P Pasawang… - 2006 - researchgate.net
นิพนธ์ต้นฉบับศศิธร เล่ม 10 Volume 50 หน้า 695 - 706.pmd Page 1 Chula Med J Vol. 50 No. 10
October 2006 Sirisalipoch S, Buachum V, Pasawang P, Tepmongkol S, Boonvisut S …
October 2006 Sirisalipoch S, Buachum V, Pasawang P, Tepmongkol S, Boonvisut S …
[PDF][PDF] Thyroid stunning in clinical practice: is it a real problem
M Filesi, M Colandrea, T Montesano… - Minerva …, 2009 - researchgate.net
Stunning is a phenomenon of reducing 131I uptaking activity by residual or metastatic tissue
during the follow-up of patients after total thyroidectomy for differentiated thyroid carcinoma …
during the follow-up of patients after total thyroidectomy for differentiated thyroid carcinoma …
Empiric therapy with low-dose I-131 in differentiated cancer thyroid: what is the magic number?
A Shinto, K Kamaleshwaran, D Shibu… - World Journal of …, 2013 - thieme-connect.com
Low dose radioactive iodine-131 (RAI) has been widely reported in the treatment of patients
with differentiated thyroid cancer (DTC) since 1970′ s. However, the clinical outcomes …
with differentiated thyroid cancer (DTC) since 1970′ s. However, the clinical outcomes …
The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy.
H Hfu, C Ma, J Li, F Feng, S Wu, Z Ye… - The Quarterly Journal of …, 2014 - europepmc.org
Background The aim of this study was to evaluate the efficacy of radioiodine remnant
ablation (RRA) for differentiated thyroid carcinoma (DTC) patients with an incomplete …
ablation (RRA) for differentiated thyroid carcinoma (DTC) patients with an incomplete …